Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining -1.40% today. In the last week its performance is 1.84%, and 10.14% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 71.28, so today’s gain of -1.40% is a significant step towards its target price. The GAP today is therefore -0.71%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 104340.56, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.80%.
At the current price of 64.07, it has a dividend yield of 3.56%, and its target price is 71.28. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.37, as well as a forward P/E of 11.32.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 17.71%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.25%.
Performance for the year is 19.39%. Since its IPO date on 1/2/2013, the total performance to date is 11.31%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 5542200, while its average volume is 7073.38. Whilst the total gain today was -1.40%, it did have a day high of -5.95%.
Volatility for this week has been at 1.38%, and 1.36% for the month. The 52-week low for AbbVie Inc., ABBV has been 45.08%, while the 52-week-high has reached -5.95%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.13, and the P/S is 4.22, along with a P/B of 18.46. Meanwhile it has a p/cash of 13.04.